BLOOD FIBRINOGEN INCREASED side effect
What is BLOOD FIBRINOGEN INCREASED ?Drugs associated with BLOOD FIBRINOGEN INCREASED
AMBISOME ARGATROBAN ARIXTRA AUGMENTIN CISPLATIN CITALOPRAM CYPHER EFALIZUMAB EFFEXOR MENOTROPINS SORAFENIB SULFASALAZINE TARCEVA TAXOTERE TEMODAL TEMOZOLOMIDE TRILEPTAL TYSABRI VELCADE VIDAZABLOOD FIBRINOGEN INCREASED : Tysabri Side Effects Report #5639955-6
Consumer or non-health professional from GERMANY reported TYSABRI problem on Feb 12, 2008. Female patient, 30 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, immune system disorder, opportunistic infection, pneumonia, staphylococcal sepsis, urge incontinence, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Vidaza Side Effects Report #5578214-7
VIDAZA problem was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, platelet count decreased, pulmonary embolism, . VIDAZA dosage: 156 MG, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDOFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Temodal Side Effects Report #5506239-6
Physician from JAPAN reported TEMODAL problem on Oct 25, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with anaplastic astrocytoma, recurrent cancer and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, deep vein thrombosis, dehydration, fibrin degradation products increased, intracranial tumour haemorrhage, neoplasm progression, pneumonia, . TEMODAL dosage: 150 MG/M2; QD; PO. During the same period patient was treated with SELBEX, LEXIN, SELENICA, PROTECADIN, MAGNESIUM OXIDE, RINDERON. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Vidaza Side Effects Report #5534154-0
VIDAZA problem was reported by a Physician from UNITED KINGDOM on Nov 15, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, international normalised ratio decreased, pulmonary embolism, . VIDAZA dosage: (156 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Augmentin Side Effects Report #5402688-5
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on July 25, 2007. Male patient, 29 years of age, was diagnosed with postoperative care and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, cyanosis, hyperhidrosis, hyperthermia, neutrophil count increased, obstructive airways disorder, sepsis, tachycardia, . AUGMENTIN dosage: unknown. During the same period patient was treated with TOPALGIC, DEPAKENE, LOXAPAC, CLOZAPINE, RISPERDAL, NORSET, PARKINANE, SCOPODERM. Patient was hospitalized. Patient died on 11/22/2006.
BLOOD FIBRINOGEN INCREASED : Argatroban Side Effects Report #5422308-3
ARGATROBAN problem was reported by a Health Professional from JAPAN on Aug 02, 2007. Male patient, 71 years of age, was diagnosed with cerebral thrombosis and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, deep vein thrombosis, hepatic function abnormal, liver disorder, pneumonia aspiration, restlessness, . ARGATROBAN dosage: 60 MG, BID, INTRAVENOUS. During the same period patient was treated with RADICUT, GRTPA, ISOSORBIDE DINITRATE, LOW MOLECULAR DEXTRAN, FAMOTIDINE, ASPIRINA BAYER, LANSOPRAZOLE. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Cypher Side Effects Report #5402375-3
Pharmacist from UNITED STATES reported CYPHER STENT problem on July 30, 2007. Male patient, 73 years of age, weighting 185.0 lb, was diagnosed with angina pectoris and was treated with CYPHER STENT. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, chills, fibrin d dimer increased, leukopenia, pyrexia, rash, thrombocytopenia, . CYPHER STENT dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Cypher Side Effects Report #5402375-3
CYPHER STENT problem was reported by a Pharmacist from UNITED STATES on July 30, 2007. Male patient, 73 years of age, weighting 185.0 lb, was diagnosed with angina pectoris and was treated with CYPHER STENT. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen increased, chills, fibrin d dimer increased, leukopenia, pyrexia, rash, thrombocytopenia, . CYPHER STENT dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Tysabri Side Effects Report #5670153-6
Physician from GERMANY reported TYSABRI problem on Feb 28, 2008. Male patient, 45 years of age, weighting 191.8 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood fibrinogen increased, mean cell haemoglobin increased, peritonsillar abscess, red blood cell count decreased, tonsillitis, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Velcade Side Effects Report #5683532-8
VELCADE problem was reported by a Physician from FRANCE on Mar 17, 2008. Female patient, 54 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood fibrinogen increased, breath sounds abnormal, chest pain, condition aggravated, cough, cytolytic hepatitis, dyspnoea, ear, nose and throat examination abnormal, . VELCADE dosage: unknown. During the same period patient was treated with MELPHALAN, PROPRANOLOL, VALACYCLOVIR, PREVISCAN, PAROXETINE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Effexor Side Effects Report #5688487-8
Physician from FRANCE reported EFFEXOR problem on Mar 25, 2008. Male patient, weighting 143.3 lb, was diagnosed with depression, mesothelioma and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, blood fibrinogen increased, eosinophil count decreased, fibrin d dimer increased, haemoglobin decreased, haptoglobin increased, lymphocyte count decreased, thrombocytopenia, . EFFEXOR dosage: unknown. During the same period patient was treated with FOLIC ACID, CYANOCOBALAMIN, CISPLATIN, ALIMTA. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Trileptal Side Effects Report #5592839-4
TRILEPTAL problem was reported by a Consumer or non-health professional from FRANCE on Jan 08, 2008. Male patient, 80 years of age, was diagnosed with epilepsy, hypertension and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood fibrinogen increased, bradycardia, bundle branch block right, c-reactive protein increased, dyspnoea, electrocardiogram repolarisation abnormality, fibrin d dimer increased, hypotension, . TRILEPTAL dosage: 300 MG, BID. During the same period patient was treated with ACUITEL, TENORMIN, SELEGILINE, LASIX. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Efalizumab Side Effects Report #5535571-5
Physician from SWITZERLAND reported EFALIZUMAB problem on Nov 30, 2007. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, . EFALIZUMAB dosage: 0.8 ML, 1/WEEK. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Tarceva Side Effects Report #5536557-7
TARCEVA problem was reported by a Physician from ITALY on Nov 19, 2007. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood ph increased, cyanosis, dyspnoea, fatigue, fibrin d dimer increased, haemoglobin decreased, . TARCEVA dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Arixtra Side Effects Report #5537417-8
Consumer or non-health professional from FRANCE reported ARIXTRA problem on Nov 28, 2007. Female patient, 55 years of age, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, deep vein thrombosis, haematoma, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with ZESTORETIC, SPECIAFOLDINE, NEXEN, TARDYFERON, MORPHINE, PERFALGAN. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Arixtra Side Effects Report #5557624-8
ARIXTRA problem was reported by a Consumer or non-health professional from FRANCE on Dec 06, 2007. Female patient, 55 years of age, weighting 149.9 lb, was diagnosed with deep vein thrombosis and was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, deep vein thrombosis, haematoma, . ARIXTRA dosage: 2.5MG PER DAY. During the same period patient was treated with ZESTORETIC, SPECIAFOLDINE, NEXEN, TARDYFERON, MORPHINE, PERFALGAN. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Taxotere Side Effects Report #5570312-7
Consumer or non-health professional from UNITED STATES reported TAXOTERE problem on Dec 19, 2007. Male patient, 60 years of age, weighting 127.8 lb, was diagnosed with neoplasm malignant and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood fibrinogen increased, faeces discoloured, international normalised ratio increased, melaena, platelet count increased, prothrombin time prolonged, . TAXOTERE dosage: 76.5 MG IV Q 21 DAYS. During the same period patient was treated with OXALIPLATIN, ATELONOLOL, DEXAMETHASONE, FILGRASTIM, HYDROCODONE BITARTRATE, NIRTOGLYCERINE, ENSURE, ONDANSETRON. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Sulfasalazine Side Effects Report #5528516-5
SULFASALAZINE problem was reported by a Health Professional from FRANCE on Nov 14, 2007. Male patient, 57 years of age, was diagnosed with colitis ulcerative and was treated with SULFASALAZINE. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood fibrinogen increased, c-reactive protein increased, colitis ulcerative, condition aggravated, cough, fatigue, hyperhidrosis, malaise, . SULFASALAZINE dosage: unknown. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Sorafenib Side Effects Report #5649427-0
Physician from BELGIUM reported SORAFENIB problem on Feb 29, 2008. Female patient, 62 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: anaemia, aplasia, blood fibrinogen increased, bone marrow failure, catheter related complication, condition aggravated, constipation, diarrhoea, electrolyte imbalance, . SORAFENIB dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Ambisome Side Effects Report #5673965-8
AMBISOME problem was reported by a Health Professional from ITALY on Feb 28, 2008. Male patient, 58 years of age, was diagnosed with myelofibrosis, graft versus host disease and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, blood fibrinogen increased, diarrhoea, fatigue, pancreatitis, peritoneal effusion, thrombocytopenic purpura, . AMBISOME dosage: 3 MG/KG, 3XWEEKLY, IV NOS; 7 MG/KG, WEEKLY, IV NOS. During the same period patient was treated with CYCLOSPORINE, ATENOLOL, ACYCLOVIR, BACTRIM DS, OMEPRAZOLE, ASPIRIN, FOLIC ACID. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Citalopram Side Effects Report #5587155-0
Health Professional from ITALY reported CITALOPRAM HYDROBROMIDE problem on Dec 22, 2007. Male patient, 78 years of age, weighting 163.1 lb, was diagnosed with depression and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood creatine increased, blood fibrinogen increased, epistaxis, haematocrit decreased, haemoglobin decreased, international normalised ratio decreased, lymphocyte count decreased, mean cell volume decreased, . CITALOPRAM HYDROBROMIDE dosage: 10 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, MONOKET, CARDIOASPIRIN, ESOPRAL, FINASTID, ITRIN. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Temozolomide Side Effects Report #5564333-8
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 206.4 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: anaemia, aspiration, blood fibrinogen increased, epistaxis, fibrin d dimer increased, haemoglobin decreased, haemoptysis, pulmonary embolism, pulmonary haemorrhage, . TEMOZOLOMIDE dosage: 4950 MG. During the same period patient was treated with BACTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Cisplatin Side Effects Report #5381894-2
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 06, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer, bone disorder and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood calcium decreased, blood fibrinogen increased, blood potassium decreased, blood pressure decreased, blood sodium decreased, dehydration, diarrhoea, dyspnoea, . CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DURAGESIC, METAMIZOLE, OMEPRAZOLE, FORTECORTIN, DUPHALAC. Patient was hospitalized. Patient died on 06/16/2007.
BLOOD FIBRINOGEN INCREASED : Menotropins Side Effects Report #5392790-9
MENOTROPINS problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Female patient, 29 years of age, was treated with MENOTROPINS. After drug was administered, patient experienced the following problems/side effects: abdominal distension, ascites, blood fibrinogen increased, chest discomfort, haematocrit increased, haemoconcentration, haemoglobin increased, laboratory test abnormal, . MENOTROPINS dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.
BLOOD FIBRINOGEN INCREASED : Cisplatin Side Effects Report #5381894-2
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on July 06, 2007. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer, bone disorder and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood calcium decreased, blood fibrinogen increased, blood potassium decreased, blood pressure decreased, blood sodium decreased, dehydration, diarrhoea, dyspnoea, . CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DURAGESIC, METAMIZOLE, OMEPRAZOLE, FORTECORTIN, DUPHALAC. Patient was hospitalized. Patient died on 06/16/2007.
BLOOD FIBRINOGEN INCREASED : Menotropins Side Effects Report #5392790-9
MENOTROPINS problem was reported by a Consumer or non-health professional from JAPAN on July 04, 2007. Female patient, 29 years of age, was treated with MENOTROPINS. After drug was administered, patient experienced the following problems/side effects: abdominal distension, ascites, blood fibrinogen increased, chest discomfort, haematocrit increased, haemoconcentration, haemoglobin increased, laboratory test abnormal, . MENOTROPINS dosage: unknown. During the same period patient was treated with CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.